Solheim JC - Search Results

1

Amyloid precursor protein and amyloid precursor-like protein 2 in cancer.

Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC. Pandey P, et al. Among authors: solheim jc. Oncotarget. 2016 Apr 12;7(15):19430-44. doi: 10.18632/oncotarget.7103. Oncotarget. 2016. PMID: 26840089 Free PMC article. Review.

2

The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expression.

Morris CR, Petersen JL, Vargas SE, Turnquist HR, McIlhaney MM, Sanderson SD, Bruder JT, Yu YY, Burgert HG, Solheim JC. Morris CR, et al. Among authors: solheim jc. J Biol Chem. 2003 Apr 11;278(15):12618-23. doi: 10.1074/jbc.M208203200. Epub 2002 Dec 27. J Biol Chem. 2003. PMID: 12506118 Free article.

3

Association of intracellular proteins with folded major histocompatibility complex class I molecules.

Morris CR, Reber AJ, Petersen JL, Vargas SE, Solheim JC. Morris CR, et al. Among authors: solheim jc. Immunol Res. 2004;30(2):171-9. doi: 10.1385/IR:30:2:171. Immunol Res. 2004. PMID: 15477658 Review.

4

Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.

Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK. Chen Z, et al. Among authors: solheim jc. Cancer Res. 2005 Oct 1;65(19):9004-11. doi: 10.1158/0008-5472.CAN-05-0885. Cancer Res. 2005. PMID: 16204074

5

CCL21-induced immune cell infiltration.

Ashour AE, Turnquist HR, Singh RK, Talmadge JE, Solheim JC. Ashour AE, et al. Among authors: solheim jc. Int Immunopharmacol. 2007 Feb;7(2):272-6. doi: 10.1016/j.intimp.2006.10.004. Epub 2006 Nov 13. Int Immunopharmacol. 2007. PMID: 17178395

6

Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection.

Solheim JC, Reber AJ, Ashour AE, Robinson S, Futakuchi M, Kurz SG, Hood K, Fields RR, Shafer LR, Cornell D, Sutjipto S, Zurawski S, LaFace DM, Singh RK, Talmadge JE. Solheim JC, et al. Cancer Gene Ther. 2007 Apr;14(4):364-71. doi: 10.1038/sj.cgt.7701018. Epub 2007 Jan 19. Cancer Gene Ther. 2007. PMID: 17235356

7

CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity.

Turnquist HR, Lin X, Ashour AE, Hollingsworth MA, Singh RK, Talmadge JE, Solheim JC. Turnquist HR, et al. Among authors: solheim jc. Int J Oncol. 2007 Mar;30(3):631-9. Int J Oncol. 2007. PMID: 17273764

8

CCL21 is an effective surgical neoadjuvant for treatment of mammary tumors.

Ashour AE, Lin X, Wang X, Turnquist HR, Burns NM, Tuli A, Sadanandam A, Suleiman K, Singh RK, Talmadge JE, Solheim JC. Ashour AE, et al. Among authors: solheim jc. Cancer Biol Ther. 2007 Aug;6(8):1206-10. doi: 10.4161/cbt.6.8.4405. Epub 2007 May 7. Cancer Biol Ther. 2007. PMID: 17617742

9

Specificity of amyloid precursor-like protein 2 interactions with MHC class I molecules.

Tuli A, Sharma M, Naslavsky N, Caplan S, Solheim JC. Tuli A, et al. Among authors: solheim jc. Immunogenetics. 2008 Jun;60(6):303-13. doi: 10.1007/s00251-008-0296-0. Epub 2008 May 2. Immunogenetics. 2008. PMID: 18452037 Free PMC article.

10

Amyloid precursor-like protein 2 increases the endocytosis, instability, and turnover of the H2-K(d) MHC class I molecule.

Tuli A, Sharma M, McIlhaney MM, Talmadge JE, Naslavsky N, Caplan S, Solheim JC. Tuli A, et al. Among authors: solheim jc. J Immunol. 2008 Aug 1;181(3):1978-87. doi: 10.4049/jimmunol.181.3.1978. J Immunol. 2008. PMID: 18641335 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters